Hosted By: Andrea Charles
About this Podcast...
In this podcast Mark Hembarsky, Vice President and Site Leader of the Aptuit Medicines Research Centre in Verona, Italy, and his colleagues Mauro Corsi, Head of Assay Development and In Vitro Profiling Preclinical Technologies, Sergio Raimondo, Head of Scientific Strategy Preclinical Safety, Phil Gerrard Head of Preclinical Pharmacology and Stefano Zancan, Head of Clinical Trial Management, join Andrea Charles from Pharma IQ, to share their scientific and technological expertise and provide an insight into the Aptuit Medicines Research Centre.
In this interview they discuss improving the success rates of therapeutic candidates in clinical development, making more efficient go/no-go decisions, challenges and investment considerations for biomarkers in early clinical development and the changing dynamics of the sponsor-CRO relationship.
 |
Have Your Say Rate this feature and give us your feedback in the comments section below |
By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product.
-
Clinical Trial Supply
Congress Center Basel, Basel, Switzerland
January 30- 1, 2013 -
2nd Annual Early Phase Clinical Trials Asia
Venue to be Confirmed, Singapore
August 28- 29, 2012 -
4th Clinical Trials Supply & Logistics Summit
San Francisco, CA
June 25- 27, 2012 -
Innovations in Phase 1 Clinical Development
Boston, MA
June 25- 27, 2012
-
Career Spotlight: Pharma Regulatory Affairs
Pharma regulatory affairs professionals play an essential role in ensuring all pharmaceutical products... Read more
Pharma IQ
-
Pharma IQ Publish Big Pharma Global Recession Report - 44.4% Fear Redundancy in 2012
---For immediate release--- In the wake of high profile staff cuts at multinational global pharmaceutical... Read more
Pharma IQ News
-
Targeting New Markets to Improve Pharma Sales Force Effectiveness
Sales force effectiveness is highly important for companies within the pharmaceutical industry. ... Read more
Pharma IQ
-
Europe Remains Most Important for Patent Strategies for 83.3% of Pharma Firms
Right across the global pharmaceutical industry, companies are desperately seeking to diversify their... Read more
Pharma IQ
|
Reach Pharma professionals through cost-effective marketing opportunities to deliver your message, position yourself as a thought leader, and introduce new products, techniques and strategies to the market.
Learn More >> Join today and interact with a vibrant network of pharma professionals, keeping up to date with the pharma industry by accessing our wealth of Pharma articles, videos, online seminars, live conferences and more. Sign Up Today! |
| Pharma IQ, a division of IQPC 2012 All rights reserved. Use of this site constitutes acceptance of our User Agreement and Privacy Policy. Careers With IQPC | Contact Us | Unsubscribe to Bizo | About Us |
|
Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!